Cotecna, a leading provider of Testing, Inspection and Certification (TIC) services, announced the acquisition of Energon ...
Median 234 days from first CRO contact to site activation, range 74 to 657; median ethics approval 48 days, median governance ...
Proprietary BRiSC™ platform to advance the discovery and development of next-generation dual-targeting siRNA medicines.
NTL HEALTHCARE, a women's health AI company, announced the global launch of CerviCARE® AI AT, an on-premises version of its ...
Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics ...
IVI Institute, the global leader in fertility care, announced that The World Egg and Sperm Bank (TWESB), a trusted provider ...
Under the terms of the agreement, Rona will receive upfront and near-term milestone payments of up to $100M and is eligible ...
Funding Will Accelerate Development of a Nanofluidic Antiretroviral Implant Designed to Deliver Continuous HIV Protection for ...
NueCell Bio, a translational development partner that helps advance cell therapies from scientific discovery to GMP readiness ...
CellCarta Partners with Waters Corporation to Advance Companion Diagnostics and Next-Generation Flow Cytometry ...
Takeda’s First-in-Class Narcolepsy Drug ORZEYFUL Enters Japan and China Markets Following Regulatory Approvals ...
- Celltrion, Inc. (KRX:068270) has announced its participation in the United European Gastroenterology (UEG) Week 2026 to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results